These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1709421)

  • 1. CSF monoamine metabolites, cholinesterases and lactate in the adult hydrocephalus syndrome (normal pressure hydrocephalus) related to CSF hydrodynamic parameters.
    Malm J; Kristensen B; Ekstedt J; Adolfsson R; Wester P
    J Neurol Neurosurg Psychiatry; 1991 Mar; 54(3):252-9. PubMed ID: 1709421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholinesterase activities and monoamine metabolite levels in the cerebrospinal fluid of patients with Alzheimer's disease.
    Kawakatsu S; Morinobu S; Shinohara M; Totsuka S; Kobashi K
    Biol Psychiatry; 1990 Sep; 28(5):387-400. PubMed ID: 1698467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF concentration gradients of monoamine metabolites in patients with hydrocephalus.
    Malm J; Kristensen B; Ekstedt J; Wester P
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1026-33. PubMed ID: 7522267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine metabolite concentrations and cholinesterase activities in cerebrospinal fluid of progressive dementia patients: relation to clinical parameters.
    Wester P; Eriksson S; Forsell A; Puu G; Adolfsson R
    Acta Neurol Scand; 1988 Jan; 77(1):12-21. PubMed ID: 2451393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine acid metabolites and cerebrospinal fluid dynamics in normal pressure hydrocephalus: preliminary results.
    Maira G; Bareggi SR; Di Rocco C; Calderini G; Morselli PL
    J Neurol Neurosurg Psychiatry; 1975 Feb; 38(2):123-8. PubMed ID: 1151392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional cerebral blood flow, white matter abnormalities, and cerebrospinal fluid hydrodynamics in patients with idiopathic adult hydrocephalus syndrome.
    Kristensen B; Malm J; Fagerland M; Hietala SO; Johansson B; Ekstedt J; Karlsson T
    J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):282-8. PubMed ID: 8609504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metabolism in Alzheimer's dementia: studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects.
    Nybäck H; Nyman H; Blomqvist G; Sjögren I; Stone-Elander S
    J Neurol Neurosurg Psychiatry; 1991 Aug; 54(8):672-8. PubMed ID: 1719135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease.
    Sjögren M; Minthon L; Passant U; Blennow K; Wallin A
    Neurobiol Aging; 1998; 19(5):379-84. PubMed ID: 9880039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: its relationship to severity of dementia and monoamine metabolites.
    Pomara N; Singh RR; Deptula D; LeWitt PA; Bissette G; Stanley M; Nemeroff CB
    Biol Psychiatry; 1989 Sep; 26(5):500-4. PubMed ID: 2477071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical responses to therapy in Alzheimer's disease and multi-infarct dementia.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Romani A; Pola A; Zerbi F; Savoldi F
    Eur Arch Psychiatry Neurol Sci; 1989; 239(2):79-86. PubMed ID: 2478368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.
    Langlais PJ; Walsh FX; Bird ED; Levy HL
    Pediatrics; 1985 Mar; 75(3):580-6. PubMed ID: 2579365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF neurotransmitter metabolites and neuropsychiatric symptomatology in patients with normal pressure hydrocephalus.
    Markianos M; Lafazanos S; Koutsis G; Sfagos C; Seretis A
    Clin Neurol Neurosurg; 2009 Apr; 111(3):231-4. PubMed ID: 19046799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF cholinesterase in early-onset and late-onset Alzheimer's disease and multi-infarct dementia of Chinese patients.
    Shen ZX; Ding Q; Wei CZ; Ding MC; Meng JM
    Acta Neurol Scand; 1993 Jan; 87(1):19-24. PubMed ID: 8424308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ; Bird ED; McEntee WJ
    Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid of patients with senile dementia of Alzheimer's type shows an increased inhibition of alpha-chymotrypsin.
    Licastro F; Davis LJ; Morini MC; Cucinotta D; Savorani G
    Alzheimer Dis Assoc Disord; 1994; 8(4):241-9. PubMed ID: 7888154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF monoamine metabolites in depression and schizophrenia.
    Berger PA; Faull KF; Kilkowski J; Anderson PJ; Kraemer H; Davis KL; Barchas JD
    Am J Psychiatry; 1980 Feb; 137(2):174-80. PubMed ID: 7352572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of neurotransmitter in forensic medicine (report II). A simple and simultaneous analysis of the major monoamine metabolites in human cerebrospinal fluid by high performance liquid chromatography with electrochemical detection.
    Endo T; Nishida A; Kano S
    Nihon Hoigaku Zasshi; 1987 Feb; 41(1):4-9. PubMed ID: 2439728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.